These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chronic ET(A) receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice. d'Uscio LV; Barton M; Shaw S; Lüscher TF Cardiovasc Res; 2002 Feb; 53(2):487-95. PubMed ID: 11827700 [TBL] [Abstract][Full Text] [Related]
4. Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide. Ruschitzka F; Quaschning T; Noll G; deGottardi A; Rossier MF; Enseleit F; Hürlimann D; Lüscher TF; Shaw SG Circulation; 2001 Jun; 103(25):3129-35. PubMed ID: 11425780 [TBL] [Abstract][Full Text] [Related]
5. Role of ET(A) receptors in the regulation of vascular reactivity in rats with congestive heart failure. Thorin E; Lucas M; Cernacek P; Dupuis J Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H844-51. PubMed ID: 10924085 [TBL] [Abstract][Full Text] [Related]
6. Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet. Giardina JB; Green GM; Rinewalt AN; Granger JP; Khalil RA Hypertension; 2001 Feb; 37(2 Pt 2):516-23. PubMed ID: 11230328 [TBL] [Abstract][Full Text] [Related]
7. Chronic blockade of endothelin ETA receptors improves flow dependent dilation in resistance arteries of hypertensive rats. Iglarz M; Matrougui K; Lévy BI; Henrion D Cardiovasc Res; 1998 Sep; 39(3):657-64. PubMed ID: 9861309 [TBL] [Abstract][Full Text] [Related]